|Articles|March 15, 2004
FDA approves generic equivalent to ophthalmic ointment
The FDA has approved Akorn Inc.'s abbreviated new drug application for neomycin and polymyxin B sulfates, and bacitracin zinc ophthalmic ointment USP, a generic therapeutic equivalent to Monarch Pharmaceuticals' Neosporin ophthalmic ointment.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
 
 



























